天康生物 (002100.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(天康生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 14,705,995,884.828,963,149,801.463,890,843,979.4816,731,607,636.1112,885,513,743.098,008,625,554.643,391,929,405.09
 营业收入(元) 14,705,995,884.828,963,149,801.463,890,843,979.4816,731,607,636.1112,885,513,743.098,008,625,554.643,391,929,405.09
二、营业总成本(元) 15,185,082,263.259,367,051,782.513,865,300,990.3516,354,974,656.8112,688,937,065.728,166,601,453.043,497,856,389.13
 营业成本(元) 14,102,713,411.338,673,203,407.283,549,707,162.0914,974,833,459.8211,631,990,452.607,462,126,920.383,144,319,839.04
 研发费用(元) 178,179,797.1298,737,400.7040,156,984.48181,061,744.95122,345,021.8778,670,194.7538,129,010.71
 营业税金及附加(元) 33,248,413.2721,117,941.649,863,979.3539,208,956.2624,491,642.1216,793,873.036,743,963.52
 销售费用(元) 390,582,458.45249,046,818.36106,983,141.48475,205,826.38364,805,459.37233,652,851.04102,896,660.62
 管理费用(元) 323,158,998.31218,252,469.31104,830,863.20476,877,832.23386,438,066.90263,941,933.60146,883,773.68
 财务费用(元) 157,199,184.77106,693,745.2253,758,859.75207,786,837.17158,866,422.86111,415,680.2458,883,141.56
  其中:利息费用(元) 199,671,196.92139,179,255.5170,835,550.29242,993,618.82187,969,164.65143,703,405.0565,260,259.74
  其中:利息收入(元) 44,012,171.9030,063,007.8415,057,085.6737,707,817.6023,941,602.0314,748,870.137,096,672.03
三、其他经营收益
 加:公允价值变动收益(元) -12,170.00-122,110.0015,270.00--61,600.00-53,680.00-516,440.00
 加:投资收益(元) 3,557,400.481,529,523.041,139,551.8217,082,869.7412,831,937.555,761,278.918,040,381.48
  其中:对联营企业和合营企业的投资收益(元) 1,619,816.991,293,073.181,139,551.8213,330,287.4112,791,382.545,761,278.914,120,673.62
 资产处置收益(元) 5,989,878.76-5,332,481.88-2,711,470.56-28,982,363.01-353,842.89829,010.12104,445.20
 资产减值损失(元) -49,364,048.98-47,383,933.55--106,616,858.9454,816,890.1054,816,890.1047,726,621.31
 信用减值损失(元) -50,654,794.28-40,164,295.23-21,500,860.35-45,725,799.13-40,392,190.07-38,799,538.46-44,418,554.09
 其他收益(元) 36,053,238.8713,229,810.378,345,527.0164,219,453.0225,201,586.7918,622,466.867,234,780.66
四、营业利润(元) -533,516,873.58-482,145,468.3010,831,007.05276,610,280.98248,619,458.85-116,799,470.87-87,755,749.48
 加:营业外收入(元) 1,648,191.31498,164.59262,711.971,679,383.99992,969.65704,883.77150,115.58
 减:营业外支出(元) 35,321,148.2816,875,435.017,142,300.5042,448,185.2931,658,744.5322,909,259.0110,190,009.50
五、利润总额(元) -567,189,830.55-498,522,738.723,951,418.52235,841,479.68217,953,683.97-139,003,846.11-97,795,643.40
 减:所得税费用(元) 21,611,408.8921,841,669.6521,100,463.8321,696,308.9125,813,766.7723,086,908.8310,771,066.79
六、净利润(元) -588,801,239.44-520,364,408.37-17,149,045.31214,145,170.77192,139,917.20-162,090,754.94-108,566,710.19
(一)按经营持续性分类
  持续经营净利润(元) -588,801,239.44-520,364,408.37-17,149,045.31214,145,170.77192,139,917.20-162,090,754.94-108,566,710.19
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -504,382,106.12-447,288,636.14-14,282,251.76301,548,661.86257,958,881.22-97,480,353.54-69,605,796.25
  少数股东损益(元) -84,419,133.32-73,075,772.23-2,866,793.55-87,403,491.09-65,818,964.02-64,610,401.40-38,960,913.94
 扣除非经常性损益后的净利润(元) -512,007,860.22-440,325,695.22-13,686,317.97313,934,261.71261,005,373.40-101,226,723.17-70,071,738.50
七、每股收益
 一、基本每股收益(元) -0.37-0.33-0.010.220.19-0.07-0.05
 二、稀释每股收益(元) -0.37-0.33-0.010.220.19-0.07-0.05
八、其他综合收益(元) 2,814,083.8322,490,620.319,848,219.0710,794,115.87-12,772,612.10-28,013,100.33-79,575,448.95
 归属于母公司股东的其他综合收益(元) 3,095,526.6121,100,559.699,848,219.0710,592,956.72-12,772,612.10-28,013,100.33-79,575,448.95
 归属于少数股东的其他综合收益(元) -281,442.781,390,060.62-201,159.15---
九、综合收益总额(元) -585,987,155.61-497,873,788.06-7,300,826.24224,939,286.64179,367,305.10-190,103,855.27-188,142,159.14
 归属于母公司所有者的综合收益总额(元) -501,286,579.51-426,188,076.45-4,434,032.69312,141,618.58245,186,269.12-125,493,453.87-149,181,245.20
 归属于少数股东的综合收益总额(元) -84,700,576.10-71,685,711.61-2,866,793.55-87,202,331.94-65,818,964.02-64,610,401.40-38,960,913.94
公告日期 2023-10-312023-08-262023-04-292023-04-292022-10-282022-08-242022-04-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院